| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Health and Wellness | | | | | | | 18.4 | |
| Heritage Labs | | | | | | | 13.7 | |
| Hooper Holmes Services | | | | | | | 19.0 | |
| Intercompany eliminations | | | | | | | 2.0 | |
| Total revenues | 56.2 | 34.3 | 0.0 | 28.5 | 24.2 | 22.1 | 51.1 | 166.4 |
| Revenue growth | 63.9% | | -100.0% | 18.0% | 9.2% | -56.7% | -69.3% | -8.8% |
| Cost of goods sold | 44.5 | 26.4 | 0.0 | 21.7 | 17.8 | 15.2 | 37.5 | 122.9 |
| Gross profit | 11.7 | 7.9 | 0.0 | 6.8 | 6.4 | 6.9 | 13.6 | 43.5 |
| Gross margin | 20.8% | 22.9% | | 23.8% | 26.5% | 31.3% | 26.5% | 26.1% |
| Selling, general and administrative | 22.3 | 14.5 | 14.0 | 14.1 | 17.6 | 16.1 | 21.3 | 42.2 |
| Other operating expenses | | | -14.0 | -0.7 | -3.4 | 0.5 | -0.1 | |
| EBITDA [+] | -7.0 | -4.0 | | -5.4 | -5.5 | -5.4 | -4.0 | 6.2 |
| EBITDA growth | 74.0% | | -100.0% | -2.6% | 1.8% | 35.9% | -164.6% | -15.4% |
| EBITDA margin | -12.5% | -11.8% | | -18.9% | -22.9% | -24.6% | -7.8% | 3.7% |
| Depreciation | 1.4 | 1.3 | | 1.2 | 2.2 | 4.0 | 3.7 | 4.5 |
| EBITA | -8.4 | -5.4 | 0.0 | -6.6 | -7.7 | -9.4 | -7.7 | 1.7 |
| EBITA margin | -15.0% | -15.7% | | -23.2% | -32.0% | -42.6% | -15.0% | 1.0% |
| Amortization of intangibles | 2.2 | 1.3 | | | | 0.2 | | 0.4 |
| EBIT [+] | -10.6 | -6.7 | 0.0 | -6.6 | -7.7 | -9.6 | -7.7 | 1.3 |
| EBIT growth | 59.5% | | -100.0% | -14.5% | -19.6% | 25.4% | -679.2% | 674.9% |
| EBIT margin | -19.0% | -19.5% | | -23.2% | -32.0% | -43.5% | -15.0% | 0.8% |
| Non-recurring items [+] | 2.9 | 0.6 | | -1.0 | 4.4 | 0.1 | 0.1 | 1.1 |
| Asset impairment | | | | | 0.2 | 0.0 | | 0.1 |
| Loss (gain) on sale of assets | | | | -1.8 | | | | |
| Loss (gain) on sale of business | | | | 0.7 | 3.4 | 0.1 | 0.1 | |
| Interest expense, net [+] | 3.2 | 3.6 | | | 0.1 | 0.0 | 0.0 | -0.1 |
| Interest expense | 3.2 | 3.6 | | | 0.1 | 0.0 | 0.0 | 0.0 |
| Interest income | | | | | | 0.0 | 0.1 | 0.1 |
| Other income (expense), net [+] | | 0.9 | | -0.2 | -0.4 | 0.0 | 0.0 | 1.3 |
| Gain (loss) on sale of business | | | | 0.7 | 3.4 | 0.1 | 0.1 | |
| Other | | 0.9 | | -0.2 | -0.4 | 0.0 | 0.0 | 1.3 |
| Pre-tax income | -16.7 | -9.9 | 0.0 | -5.9 | -12.7 | -9.8 | -7.8 | 1.6 |
| Income taxes | -0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
| Tax rate | 3.9% | | | | | | | 13.7% |
| Earnings from continuing ops | -16.1 | -9.9 | | -5.9 | -12.7 | -9.8 | -7.8 | 1.4 |
| Earnings from discontinued ops | | | | -3.3 | -2.0 | -7.9 | 4.2 | 0.1 |
| Net income | -16.0 | -10.3 | 0.0 | -8.5 | -11.3 | -17.6 | -3.5 | 1.5 |
| Net margin | -28.4% | -30.1% | | -29.7% | -46.6% | -79.5% | -6.9% | 0.9% |
| |
| Basic EPS [+] | ($0.75) | ($1.11) | | ($0.08) | ($0.18) | ($0.14) | ($0.11) | $0.02 |
| Growth | -31.8% | | | -53.8% | 29.3% | 25.1% | -647.5% | 3699.3% |
| Diluted EPS [+] | ($0.75) | ($1.11) | | ($0.08) | ($0.18) | ($0.14) | ($0.11) | $0.02 |
| Growth | -31.8% | | | -53.8% | 29.3% | 25.1% | -651.2% | 3712.8% |
| |
| Shares outstanding (basic) [+] | 21.3 | 9.0 | | 70.7 | 70.0 | 69.7 | 69.6 | 69.4 |
| Growth | 137.4% | | | 1.0% | 0.3% | 0.2% | 0.3% | 1.1% |
| Shares outstanding (diluted) [+] | 21.3 | 9.0 | | 70.7 | 70.0 | 69.7 | 69.6 | 69.9 |
| Growth | 137.4% | | | 1.0% | 0.3% | 0.2% | -0.4% | 0.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |